Clinical Trial Update: Liposomal Bupivacaine Versus Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine to standard bupivacaine with dexamethasone for knee surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Pain Postoperative

Drugs mentioned

• Bupivacaine (standard) (bupivacaine)
• DEXAMETHASONE (Dexamethasone)
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Albany Medical College | Conditions: Osteoarthritis, Pain, Postoperative | Phase 4 | Status: WITHDRAWN